Holden v. Kijakazi

CourtDistrict Court, E.D. Missouri
DecidedMay 2, 2022
Docket4:20-cv-01858
StatusUnknown

This text of Holden v. Kijakazi (Holden v. Kijakazi) is published on Counsel Stack Legal Research, covering District Court, E.D. Missouri primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Holden v. Kijakazi, (E.D. Mo. 2022).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MISSOURI EASTERN DIVISION

LISA MARIE HOLDEN, ) ) Plaintiff, ) ) v. ) No. 4:20 CV 1858 DDN ) KILOLO KIJAKAZI,1 ) Commissioner of Social Security, ) ) Defendant. )

MEMORANDUM This action is before the Court for judicial review of the final decision of defendant the Commissioner of Social Security denying the application of plaintiff Lisa Marie Holden for disability insurance benefits under Title II of the Social Security Act, 42 U.S.C. §§ 401-434.2 The parties have consented to the exercise of plenary authority by a United States Magistrate Judge pursuant to 28 U.S.C. § 636(c). For the reasons set forth below, the decision of the Commissioner is affirmed.

I. BACKGROUND Plaintiff Lisa Marie Holden, who was born on May 31, 1969, protectively filed her application on March 13, 2019. (Tr. 15, 221-22.) She alleged a disability onset date of November 29, 2018, due to chronic obstructive pulmonary disease (COPD), fibromyalgia,

1 Kilolo Kijakazi became the Acting Commissioner of Social Security on July 9, 2021. Pursuant to Federal Rule of Appellate Procedure 43(c)(2), Kilolo Kijakazi is substituted for Andrew Saul as defendant in this action. No further action is needed for this action to continue. See 42 U.S.C. § 405(g) (last sentence).

2 Plaintiff’s brief initially alleges that defendant denied her applications for disability insurance benefits under Title II of the Social Security Act, 42 U.S.C. §§ 401-434 and supplemental security income under Title XVI of the Act, 42 U.S.C. §§ 1381, et seq. (Doc.14 at 1.) A review of the record indicates that plaintiff applied only for disability insurance benefits. diabetes, obesity, bipolar disorder, and depression. (Tr. 237, 250.) On May 31, 2019, plaintiff’s application was initially denied. (Tr. 117-21.) On July 3, 2019, plaintiff appealed the decision and requested a hearing by an administrative law judge (ALJ). (Tr. 124-25.) On April 6, 2020, plaintiff attended a hearing before an ALJ. (Tr. 41-63.) On May 26, 2020, the ALJ denied plaintiff’s application. (Tr. 12-29.) On October 29, 2020, the Appeals Council denied plaintiff’s request for review. (Tr. 1-6.) The ALJ’s decision therefore became the final decision of the Commissioner subject to judicial review by this Court under 42 U.S.C. § 405(g).

II. MEDICAL AND OTHER HISTORY The following is a summary of plaintiff’s medical and other history relevant to her appeal. On February 10, 2017, plaintiff saw Paul Simon, D.O., at Advent Medical Group, for a psychiatric follow-up. (Tr. 362.) Her chief complaints were bipolar disorder and post- traumatic stress disorder. (Id.) Plaintiff displayed normal appearance, speech, thought process, mood, attention, and judgment. (Tr. 363.) Dr. Simon prescribed various medications and discussed treatment strategies with plaintiff. (Tr. 364.) On May 11, 2017, plaintiff saw Dr. Simon for a psychiatric follow-up. (Tr. 358.) Plaintiff displayed normal appearance, speech, thought process, mood, attention, and judgment. (Tr. 359.) On August 11 and November 8, 2017, plaintiff saw Dr. Simon for psychiatric follow- ups for bipolar disorder and grief. (Tr. 351, 355.) No major change in symptoms was reported. (Tr. 351-57.) On December 4, 2017, plaintiff saw Cheryl York, registered medical assistant, for cough. (Tr. 495.) Plaintiff reported she passed out because of coughing too hard. (Id.) She had shortness of breath and wheezing. (Id.) Ms. York injected Solu-Medrol.3 (Id.)

3 Solu-Medrol is used to treat inflammation. https://www.drugs.com/mtm/solu-medrol-in jection.html. On December 18, 2017, plaintiff saw Joseph Polizzi, M.D., for a cardiology follow-up. (Tr. 492.) Plaintiff reported that she had felt very well. (Id.) She reported no shortness of breath, dyspnea4 on exertion, or wheezing. (Tr. 492-93.) The physical exam showed normal respiratory effort. (Tr. 493.) On December 27, 2017, plaintiff saw Susan Luedke, M.D., for a follow-up for her stage I breast cancer. (Tr. 491.) Plaintiff did not have shortness of breath. (Id.) The physical exam showed normal pulmonary effort and no respiratory distress, wheezes, or rales. (Id.) On February 6, 2018, plaintiff saw Adeel Khan, M.D., for a follow-up for COPD. (Tr. 486.) Plaintiff reported cough, shortness of breath, and wheezing. (Tr. 490.) The physical exam showed normal pulmonary effort and breath and no stridor, respiratory distress, wheezes, or rales.5 (Id.) On February 12, 2018, plaintiff saw Dr. Simon for a psychiatric follow-up for bipolar disorder and grief. (Tr. 347.) Dr. Simon noted that plaintiff had failed or was currently failing at least one neuropsychiatric medication. (Tr. 350.) Dr. Simon contemplated an alteration in the neuropsychiatric medication treatment. (Id.) On February 14, 2018, plaintiff saw Amanda Burkheart, D.O., for upper respiratory tract infection. (Tr. 483.) Plaintiff had chest tightness, shortness of breath, and wheezing. (Tr. 484.) The physical exam showed wheezes, some diminished breath sounds, normal pulmonary effort, and no respiratory distress. (Id.) On March 16, 2018, plaintiff saw Dr. Simon for a psychiatric follow-up for bipolar disorder and grief. (Tr. 343.) Dr. Simon noted some worsening ongoing grief which appeared significant. (Tr. 345.) On March 21, 2018, plaintiff saw Anne Voss, nurse practitioner, for a six-month check and medication refill. (Tr. 477-78.) Plaintiff reported her COPD symptoms began several years ago and included mild cough and worsening wheezing with exertion. (Tr. 477.) She

4 Dyspnea is shortness of breath. https://www.mayoclinic.org/symptoms/shortness-of- breath/basics/definition/sym-20050890.

5A rale is a small rattling, bubbling, or clicking sound in the lungs. https://medlineplus.gov/ency/article/007535.htm. could walk 50 feet before resting. (Id.) Plaintiff was satisfied with current therapies, including Symbicort6 and Albuterol7 as needed. (Id.) The physical exam showed normal pulmonary effort and breathing. (Tr. 478.) Ms. Voss noted that plaintiff’s COPD was well controlled by current therapies and did not change current therapies. (Id.) On April 3, 2018, plaintiff saw Misty Vogt, nurse practitioner, for a follow-up for hoarseness. (Tr. 474.) Plaintiff did not exhibit cough, shortness of breath, or wheezing. (Tr. 475.) On April 12, July 12, and October 5, 2018, and January 3, 2019, plaintiff saw Dr. Simon for psychiatric follow-ups for bipolar disorder, grief, and family issues. (Tr. 327, 331, 335, 339.) No major change in symptoms was reported. (Tr. 327-46.) On April 23, 2018, plaintiff saw Dr. Burkheart for chronic medical conditions. (Tr. 469.) Plaintiff had mild COPD. (Tr. 471.) She felt her symptoms were not well controlled. (Id.) Plaintiff had shortness of breath and wheezing. (Id.) The physical exam showed normal pulmonary effort, normal breathing, and no respiratory distress. (Tr. 472.) On April 27, 2018, plaintiff saw Julie Mai, M.D., for a routine follow-up. (Tr. 466-67.) She had COPD, chronic dyspnea on exertion, and cough. (Tr. 467.) She had coughed so much that she felt dizzy. (Id.) Dr. Mai advised plaintiff to stop smoking. (Id.) On May 10, 2018, plaintiff saw Dr. Khan for a follow-up for COPD. (Tr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Holden v. Kijakazi, Counsel Stack Legal Research, https://law.counselstack.com/opinion/holden-v-kijakazi-moed-2022.